GE Vernova Inc vs IDEXX Laboratories, Inc. — how do they compare? GE Vernova Inc trades at $1,036.05 (market cap $283.57B), while IDEXX Laboratories, Inc. trades at $578.25 (market cap $43.94B). The key difference: GE Vernova Inc is far larger — about 6.5× IDEXX Laboratories, Inc.'s market cap, and GE Vernova Inc pays a 0.19% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.
| GEV | IDXX | |
|---|---|---|
Market Cap | $283.57B | $43.94B |
Sector | Technology | Health |
52-Week High | $1.17K | $766.68 |
52-Week Low | $547.96 | $514.61 |
Enterprise Value | $276.21B | $44.84B |
Dividend Yield | 0.19% | — |
Signals from Pluang's Aura AI — not financial advice
GE Vernova (GEV) trades at $1,038, down 2.63% today, with mixed technical signals showing bearish overall momentum but bullish moving averages. The company demonstrates strong profitability with 23.81% net income margin and 83.23% ROE, though valuation metrics appear elevated with P/E of 30.84 and EV/EBITDA of 109.82. Recent earnings showed volatility with Q1 2026 beating expectations by a wide margin, while the company prepares for Q2 2026 results amid significant AI-driven power demand growth.
The outlook remains positive with analyst consensus strongly bullish (21 buy ratings, 0 sell) and $1,260 price target representing 21% upside. Key opportunities include AI data center power demand and $11 billion investment push, while risks include wind segment pressures and elevated valuation multiples that may limit near-term upside potential despite strong fundamentals.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
GE Vernova is a global leader in the electric power industry. It provides sustainable energy solutions across gas, wind, and hydro sectors, focusing on modernizing the world's power grids.
Read more on GEV →Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →